InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Half Yearly Report and Accounts 27 Aug 2025 9:21AM $17.800 $12.450 fallen by 30.06%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 First site initiated for Neuren's PMS Phase 3 trial 25 Aug 2025 9:27AM $17.170 $12.450 fallen by 27.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 First site initiated for Neuren's PMS Phase 3 trial 25 Aug 2025 9:27AM $17.170 $12.450 fallen by 27.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Application for quotation of securities - NEU 12 Aug 2025 4:12PM $17.880 $12.450 fallen by 30.37%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline 8 Aug 2025 9:16AM $17.550 $12.450 fallen by 29.06%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $12.450 fallen by 26.81%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $12.450 fallen by 26.81%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Change of Director's Interest Notice - J Pilcher 22 Jul 2025 9:30AM $15.170 $12.450 fallen by 17.93%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Application for quotation of securities - NEU 22 Jul 2025 9:21AM $15.170 $12.450 fallen by 17.93%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Notification regarding unquoted securities - NEU 9 Jul 2025 5:03PM $14.180 $12.450 fallen by 12.20%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Application for quotation of securities - NEU 30 Jun 2025 5:49PM $14.110 $12.450 fallen by 11.76%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 US patent allowed for NNZ-2591 to treat Pitt Hopkins 26 Jun 2025 9:25AM $12.540 $12.450 fallen by 0.72%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Notification of cessation of securities - NEU 25 Jun 2025 5:26PM $12.540 $12.450 fallen by 0.72%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 16 Jun 2025 9:28AM $13.100 $12.450 fallen by 4.96%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 16 Jun 2025 9:07AM $13.100 $12.450 fallen by 4.96%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 13 Jun 2025 8:26AM $13.900 $12.450 fallen by 10.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 12 Jun 2025 7:45AM $13.830 $12.450 fallen by 9.98%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 11 Jun 2025 8:07AM $13.990 $12.450 fallen by 11.01%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 10 Jun 2025 8:33AM $13.760 $12.450 fallen by 9.52%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 6 Jun 2025 9:13AM $13.900 $12.450 fallen by 10.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 5 Jun 2025 7:50AM $13.900 $12.450 fallen by 10.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Notification of cessation of securities - NEU 4 Jun 2025 4:30PM $13.900 $12.450 fallen by 10.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 4 Jun 2025 8:30AM $13.710 $12.450 fallen by 9.19%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 3 Jun 2025 8:38AM $13.570 $12.450 fallen by 8.25%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,575 Update - Notification of buy-back - NEU 2 Jun 2025 8:51AM $13.880 $12.450 fallen by 10.30%

51 - 75 of 808 results

Page 3 of 33

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.